Skip to main content
Journal cover image

Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?

Publication ,  Journal Article
Teitelbaum, JI; Issa, K; Barak, IR; Ackall, FY; Jung, S-H; Jang, DW; Abi Hachem, R
Published in: Otolaryngol Head Neck Surg
November 2020

OBJECTIVE: To determine whether treatment of sinonasal squamous cell carcinoma (SCC) at a high-volume facility affects survival. STUDY DESIGN: Retrospective database analysis. SETTING: National Cancer Database (2004-2014). SUBJECTS AND METHODS: The National Cancer Database was queried for sinonasal SCC from 2004 to 2014. Patient demographics, tumor characteristics and classification, resection margins, treatment regimen, and facility case-specific volume-averaged per year and grouped in tertiles as low (0%-33%), medium (34%-66%), and high (67%-100%)-were compared. Overall survival was compared with Cox proportional hazards regression analysis. RESULTS: A total of 3835 patients treated for sinonasal SCC between 2004 and 2014 were identified. Therapeutic options included surgery alone (18.6%), radiotherapy (RT) alone (29.1%), definitive chemoradiation (15.4%), surgery with adjuvant RT (22.8%), and combinations (14.1%) of the aforementioned treatments. Patients who underwent surgery with adjuvant RT had better overall survival (hazard ratio [HR], 0.74; P < .001; 95% CI, 0.63-0.86). As for treatment volume per facility, 7.4% of patients were treated at a low-volume center, 17.5% at a medium-volume center, and 75.1% at a high-volume center. Univariate analysis showed that treatment at a high-volume facility conferred a significantly better overall survival (HR, 0.77; P = .002). Multivariable Cox proportional hazards regression analysis, adjusting for age, sex, tumor classification, and treatment regimen, demonstrated that patients who underwent treatment at a high-volume facility (HR, 0.81; P < .001) had significantly improved survival. CONCLUSION: This study shows a better overall survival for sinonasal SCC treated at high-volume centers. Further study may be needed to understand the effect of case volume on the paradigms of sinonasal SCC management.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Otolaryngol Head Neck Surg

DOI

EISSN

1097-6817

Publication Date

November 2020

Volume

163

Issue

5

Start / End Page

986 / 991

Location

England

Related Subject Headings

  • Young Adult
  • United States
  • Survival Rate
  • Retrospective Studies
  • Radiotherapy, Adjuvant
  • Proportional Hazards Models
  • Paranasal Sinus Neoplasms
  • Otorhinolaryngology
  • Multivariate Analysis
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Teitelbaum, J. I., Issa, K., Barak, I. R., Ackall, F. Y., Jung, S.-H., Jang, D. W., & Abi Hachem, R. (2020). Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit? Otolaryngol Head Neck Surg, 163(5), 986–991. https://doi.org/10.1177/0194599820935395
Teitelbaum, Jordan I., Khalil Issa, Ian R. Barak, Feras Y. Ackall, Sin-Ho Jung, David W. Jang, and Ralph Abi Hachem. “Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?Otolaryngol Head Neck Surg 163, no. 5 (November 2020): 986–91. https://doi.org/10.1177/0194599820935395.
Teitelbaum JI, Issa K, Barak IR, Ackall FY, Jung S-H, Jang DW, et al. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit? Otolaryngol Head Neck Surg. 2020 Nov;163(5):986–91.
Teitelbaum, Jordan I., et al. “Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?Otolaryngol Head Neck Surg, vol. 163, no. 5, Nov. 2020, pp. 986–91. Pubmed, doi:10.1177/0194599820935395.
Teitelbaum JI, Issa K, Barak IR, Ackall FY, Jung S-H, Jang DW, Abi Hachem R. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit? Otolaryngol Head Neck Surg. 2020 Nov;163(5):986–991.
Journal cover image

Published In

Otolaryngol Head Neck Surg

DOI

EISSN

1097-6817

Publication Date

November 2020

Volume

163

Issue

5

Start / End Page

986 / 991

Location

England

Related Subject Headings

  • Young Adult
  • United States
  • Survival Rate
  • Retrospective Studies
  • Radiotherapy, Adjuvant
  • Proportional Hazards Models
  • Paranasal Sinus Neoplasms
  • Otorhinolaryngology
  • Multivariate Analysis
  • Middle Aged